Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 21, 2017; 23(35): 6420-6428
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6420
Figure 1
Figure 1 Prior disease-free survival (A) and overall survival (B) in patients with metachronous pulmonary metastases and metachronous non-pulmonary metastases. MPM: Metachronous pulmonary metastases; MNPM: Metachronous non-pulmonary metastases; DFS: Disease-free survival; OS: Overall survival.
Figure 2
Figure 2 Prior disease-free survival (A) and overall survival (B) in patients with metachronous isolated pulmonary vs metachronous pulmonary and other metastases patients. MPM: Metachronous pulmonary metastases; MIPM: Metachronous isolated pulmonary metastases; DFS: Disease-free survival; OS: Overall survival.

  • Citation: Lovecek M, Skalicky P, Chudacek J, Szkorupa M, Svebisova H, Lemstrova R, Ehrmann J, Melichar B, Yogeswara T, Klos D, Vrba R, Havlik R, Mohelnikova-Duchonova B. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature. World J Gastroenterol 2017; 23(35): 6420-6428
  • URL: https://www.wjgnet.com/1007-9327/full/v23/i35/6420.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v23.i35.6420